Alkem Laboratories Ltd
NSE :ALKEM BSE :539523 Sector : PharmaceuticalsBuy, Sell or Hold ALKEM? Ask The Analyst
BSE
prev close
OPEN PRICE
bid price (qty)
offer price (qty)
volume
Today's low / high
52 WK low / high
NSE
prev close
open price
bid price (qty)
offer price (qty)
volume
Today's' low / high
52 WK low / high
19 Nov 5529.80 (0.27%) | 18 Nov 5515.15 (-0.18%) | 14 Nov 5524.95 (-0.83%) | 13 Nov 5571.20 (1.23%) | 12 Nov 5503.40 (-2.14%) | 11 Nov 5623.85 (-1.45%) | 08 Nov 5706.50 (-0.30%) | 07 Nov 5723.80 (-2.22%) | 06 Nov 5853.80 (3.24%) | 05 Nov 5670.35 (-2.21%) | 04 Nov 5798.30 (-0.12%) | 01 Nov 5805.25 (0.45%) | 31 Oct 5779.25 (-0.28%) | 30 Oct 5795.60 (-2.24%) | 29 Oct 5928.30 (-1.84%) | 28 Oct 6039.55 (1.63%) | 25 Oct 5942.55 (-0.31%) | 24 Oct 5960.95 (1.82%) | 23 Oct 5854.55 (-4.18%) | 22 Oct 6110.25 (-0.78%) | 21 Oct 6158.35 (0.42%) |
Price Chart Historical Data Technical Chart
Technical Analysis
Short Term Investors
Very Bearish
Medium Term Investors
Very Bearish
Long Term Investors
Bullish
Moving Averages
5 DMA
Bearish
5526.41
10 DMA
Bearish
5620.04
20 DMA
Bearish
5760.23
50 DMA
Bearish
6015.79
100 DMA
Bearish
5752.44
200 DMA
Bullish
5402.68
Intraday Support and Resistance
(Based on Pivot Points) |
Updated On Nov 19, 2024 04:00 PM For Next Trading Session
Pivots | Classic | Fibonacci | Camarilla | Woodie | DM |
---|---|---|---|---|---|
R3 | 5735.54 | 5667.67 | 5567.42 | - | - |
R2 | 5667.67 | 5615.41 | 5554.88 | 5667.4 | - |
R1 | 5598.74 | 5583.13 | 5542.34 | 5598.2 | 5633.2 |
P | 5530.87 | 5530.87 | 5530.87 | 5530.6 | 5548.1 |
S1 | 5461.94 | 5478.61 | 5517.26 | 5461.4 | 5496.4 |
S2 | 5394.07 | 5446.33 | 5504.72 | 5393.8 | - |
S3 | 5325.14 | 5394.07 | 5492.18 | - | - |
Key Metrics
EPS
180.88
P/E
30.55
P/B
5.61
Dividend Yield
0.72%
Market Cap
66,117 Cr.
Face Value
2
Book Value
984.46
ROE
18.72%
EBITDA Growth
886.31 Cr.
Debt/Equity
0.15
Shareholding History
Quarterly Result (Figures in Rs. Crores)
Alkem Laboratories Ltd Quaterly Results
Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | |
INCOME | 3503.36 | 3417.51 | 3023.99 | 3152.13 | 3549.15 |
PROFIT | 664.03 | 637.37 | 303.22 | 545.16 | 688.64 |
EPS | 51.9 | 49.76 | 24.55 | 45.6 | 57.6 |
Alkem Laboratories Ltd Quaterly Results
Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | |
INCOME | 2696.43 | 2590.25 | 2449.16 | 2606.2 | 2992.16 |
PROFIT | 646.51 | 546.85 | 335 | 583.25 | 697.58 |
EPS | 54.07 | 42.17 | 27.18 | 48.78 | 58.34 |
Profit & Loss (Figures in Rs. Crores)
Alkem Laboratories Ltd Profit & Loss
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | ||
INCOME | 3958.07 | 5268.99 | 6089.14 | 6611.58 | 7441.25 | 8678.53 | 9432.06 | 11332.32 | 11352.97 | 12964.3 | |
PROFIT | 362.81 | 751.53 | 893.54 | 630.55 | 764.73 | 1126.16 | 1554.57 | 1656.06 | 1073.17 | 1894.42 | |
EPS | 0 | 62.92 | 74.45 | 53.4 | 64.71 | 96.14 | 135.32 | 140.55 | 84.22 | 151.52 |
Alkem Laboratories Ltd Profit & Loss
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | ||
INCOME | 3331.31 | 4236.38 | 4876.75 | 5473.34 | 5695.11 | 6806.75 | 7710.98 | 9390.6 | 9063.11 | 10125.02 | |
PROFIT | 337.54 | 709.35 | 884.57 | 715.41 | 801.27 | 1261.35 | 1668.59 | 1539.43 | 1144.71 | 1802.01 | |
EPS | 30.02 | 58.57 | 73.87 | 59.88 | 66.9 | 105.76 | 140.95 | 128.92 | 94.9 | 146.14 |
Balance Sheet (Figures in Rs. Crores)
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | |
SOURCES OF FUNDS : | ||||||||||
Share Capital | 23.91 | 23.91 | 23.91 | 23.91 | 23.91 | 23.91 | 23.91 | 23.91 | 23.91 | 23.91 |
Reserves Total | 10,288.15 | 9,021.38 | 8,613.99 | 7,352.82 | 6,136.76 | 5,415.43 | 4,839.86 | 4,443.73 | 3,668.05 | 2,975.14 |
Total Shareholders Funds | 10,312.06 | 9,045.29 | 8,637.9 | 7,376.73 | 6,160.67 | 5,439.34 | 4,863.77 | 4,467.64 | 3,691.96 | 2,999.05 |
Minority Interest | 402.34 | 389.71 | 209.43 | 181.28 | 148.3 | 132.61 | 121.55 | 115.23 | 95.02 | 85.65 |
Secured Loans | 428.76 | 300.57 | 1,335.32 | 686.3 | 634.43 | 459.27 | 552.14 | 387.15 | 376.59 | 942.34 |
Unsecured Loans | 989.65 | 1,096.11 | 1,332.87 | 1,105.68 | 981.09 | 484.8 | 445.42 | 272.31 | 280.91 | 363.58 |
Total Debt | 1,418.41 | 1,396.68 | 2,668.19 | 1,791.98 | 1,615.52 | 944.07 | 997.56 | 659.46 | 657.5 | 1,305.92 |
Other Liabilities | 636.69 | 544.17 | 340.67 | 259.56 | 318.08 | 187.11 | 164.6 | 113.46 | 85.61 | 75.3 |
Total Liabilities | 12,769.5 | 11,375.85 | 11,856.19 | 9,609.55 | 8,242.57 | 6,703.13 | 6,147.48 | 5,355.79 | 4,530.09 | 4,465.92 |
APPLICATION OF FUNDS : | ||||||||||
Gross Block | 4,543.71 | 4,050.26 | 4,185.6 | 3,768.85 | 3,606.95 | 3,026.09 | 2,603.78 | 1,977.2 | 1,538.64 | 1,744.89 |
Less: Accumulated Depreciation | 1,670.93 | 1,367.41 | 1,283.87 | 975.87 | 698.94 | 495.65 | 320.19 | 180.16 | 89.1 | 370.55 |
Net Block | 2,872.78 | 2,682.85 | 2,901.73 | 2,792.98 | 2,908.01 | 2,530.44 | 2,283.59 | 1,797.04 | 1,449.54 | 1,374.34 |
Capital Work in Progress | 158.57 | 323.24 | 339.48 | 393.28 | 362.97 | 492.96 | 380.97 | 299.26 | 172.42 | 110.69 |
Investments | 483.79 | 621.82 | 370.98 | 332.78 | 261.39 | 323.62 | 444.27 | 553 | 508.57 | 480.78 |
Inventories | 2,661.18 | 2,607.53 | 3,005.53 | 2,312.44 | 1,818.82 | 1,499.87 | 1,442.19 | 1,206 | 909.37 | 784.23 |
Sundry Debtors | 2,252.81 | 2,132.18 | 1,884.6 | 1,607.21 | 1,649.36 | 1,248.41 | 1,080.5 | 713.64 | 567.51 | 527.08 |
Cash and Bank Balance | 1,579.35 | 2,616.89 | 2,578.58 | 1,990.45 | 1,092.21 | 661.6 | 576.78 | 399.26 | 780.9 | 790.76 |
Loans and Advances | 3,769.25 | 1,055.87 | 827.41 | 834.34 | 775.37 | 578.37 | 567.93 | 304.68 | 236.74 | 174.93 |
Total Current Assets | 10,262.59 | 8,412.47 | 8,296.12 | 6,744.44 | 5,335.76 | 3,988.25 | 3,667.4 | 2,623.58 | 2,494.52 | 2,277 |
Current Liabilities | 2,623.54 | 1,984.61 | 1,923.08 | 1,654.14 | 1,471.42 | 1,348.83 | 1,375.19 | 1,075.09 | 876.62 | 649.07 |
Provisions | 181.86 | 396.19 | 289.92 | 255.57 | 231.55 | 155.93 | 141.29 | 136.7 | 126.94 | 84.42 |
Total Current Liabilities & Provisions | 2,805.4 | 2,380.8 | 2,213 | 1,909.71 | 1,702.97 | 1,504.76 | 1,516.48 | 1,211.79 | 1,003.56 | 733.49 |
Net Current Assets | 7,457.19 | 6,031.67 | 6,083.12 | 4,834.73 | 3,632.79 | 2,483.49 | 2,150.92 | 1,411.79 | 1,490.96 | 1,543.51 |
Deferred Tax Assets | 1,770.42 | 1,498.3 | 1,527.92 | 1,281.97 | 1,099.99 | 1,066.13 | 965.33 | 894.16 | 666.32 | 33.68 |
Deferred Tax Liability | 255.59 | 195.8 | 218.66 | 174.06 | 167.42 | 358.8 | 311.39 | 198.36 | 151.1 | 125.55 |
Net Deferred Tax | 1,514.83 | 1,302.5 | 1,309.26 | 1,107.91 | 932.57 | 707.33 | 653.94 | 695.8 | 515.22 | -91.87 |
Other Assets | 282.34 | 413.77 | 851.62 | 147.87 | 144.84 | 165.29 | 233.79 | 598.9 | 393.38 | 1,048.47 |
Total Assets | 12,769.5 | 11,375.85 | 11,856.19 | 9,609.55 | 8,242.57 | 6,703.13 | 6,147.48 | 5,355.79 | 4,530.09 | 4,465.92 |
Contingent Liabilities | 97.72 | 323.79 | 307.47 | 296.33 | 280.91 | 330.58 | 276.75 | 312.33 | 325.62 | 263.06 |
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | |
SOURCES OF FUNDS : | ||||||||||
Share Capital | 23.91 | 23.91 | 23.91 | 23.91 | 23.91 | 23.91 | 23.91 | 23.91 | 23.91 | 23.91 |
Reserves Total | 10,530.7 | 9,325.94 | 8,719.75 | 7,601.84 | 6,256.53 | 5,441.3 | 4,861.45 | 4,368.74 | 3,575.59 | 3,077.11 |
Total Shareholders Funds | 10,554.61 | 9,349.85 | 8,743.66 | 7,625.75 | 6,280.44 | 5,465.21 | 4,885.36 | 4,392.65 | 3,599.5 | 3,101.02 |
Secured Loans | 172.02 | 119.31 | 1,010.07 | 327.88 | 238.6 | 32.38 | 110.71 | 108 | 151.06 | 883.24 |
Unsecured Loans | 833.19 | 1,062.38 | 1,283.71 | 1,055.63 | 970.78 | 470.58 | 436.81 | 260.23 | 229.21 | 219.3 |
Total Debt | 1,005.21 | 1,181.69 | 2,293.78 | 1,383.51 | 1,209.38 | 502.96 | 547.52 | 368.23 | 380.27 | 1,102.54 |
Other Liabilities | 339.19 | 291.48 | 263.91 | 197.35 | 239.31 | 150.75 | 135.8 | 92.35 | 68.62 | 60.09 |
Total Liabilities | 11,899.01 | 10,823.02 | 11,301.35 | 9,206.61 | 7,729.13 | 6,118.92 | 5,568.68 | 4,853.23 | 4,048.39 | 4,263.65 |
APPLICATION OF FUNDS : | ||||||||||
Gross Block | 3,144.31 | 2,932.25 | 2,826.98 | 2,481.89 | 2,351.73 | 1,973.17 | 1,713.69 | 1,262.9 | 944.72 | 1,156.17 |
Less : Accumulated Depreciation | 1,362.07 | 1,107.16 | 944.91 | 723.53 | 514.97 | 366.79 | 242.7 | 137.27 | 70.04 | 285.71 |
Net Block | 1,782.24 | 1,825.09 | 1,882.07 | 1,758.36 | 1,836.76 | 1,606.38 | 1,470.99 | 1,125.63 | 874.68 | 870.46 |
Capital Work in Progress | 90.78 | 228.75 | 232.45 | 323.26 | 313.66 | 381.59 | 298.92 | 218.44 | 146.55 | 95.89 |
Investments | 2,828.98 | 3,005.55 | 2,528.61 | 2,152.38 | 1,956.04 | 1,695.6 | 1,544.5 | 1,517.64 | 1,157.67 | 1,070.56 |
Inventories | 1,849.56 | 1,724.66 | 1,975.73 | 1,513.26 | 1,092.58 | 991.28 | 1,024.16 | 858.76 | 590.03 | 548.24 |
Sundry Debtors | 1,753.64 | 1,768.34 | 1,768.22 | 1,556.55 | 1,555.07 | 966.64 | 875 | 633.32 | 480.44 | 375.01 |
Cash and Bank Balance | 1,065.85 | 2,163.87 | 2,297.21 | 1,673.36 | 765.61 | 397.94 | 278.3 | 199.06 | 524.03 | 633.32 |
Loans and Advances | 3,227.27 | 802.75 | 684.29 | 726.2 | 654.4 | 505.64 | 513.15 | 284.89 | 211.98 | 160.81 |
Total Current Assets | 7,896.32 | 6,459.62 | 6,725.45 | 5,469.37 | 4,067.66 | 2,861.5 | 2,690.61 | 1,976.03 | 1,806.48 | 1,717.38 |
Current Liabilities | 2,028.15 | 1,683.76 | 1,673.8 | 1,367.46 | 1,207.97 | 1,041.45 | 1,143.03 | 941.16 | 684.39 | 461.99 |
Provisions | 110.64 | 224.44 | 194.02 | 198.66 | 168.73 | 131.78 | 102.46 | 103.96 | 89.63 | 66.65 |
Total Current Liabilities & Provisions | 2,138.79 | 1,908.2 | 1,867.82 | 1,566.12 | 1,376.7 | 1,173.23 | 1,245.49 | 1,045.12 | 774.02 | 528.64 |
Net Current Assets | 5,757.53 | 4,551.42 | 4,857.63 | 3,903.25 | 2,690.96 | 1,688.27 | 1,445.12 | 930.91 | 1,032.46 | 1,188.74 |
Deferred Tax Assets | 1,540.21 | 1,292.74 | 1,248.66 | 1,143.51 | 1,005.92 | 835.63 | 759.87 | 753.12 | 555.95 | 29.2 |
Deferred Tax Liability | 253.55 | 207.82 | 199.92 | 189.08 | 186.76 | 199.04 | 181.82 | 162.12 | 146.56 | 97.71 |
Net Deferred Tax | 1,286.66 | 1,084.92 | 1,048.74 | 954.43 | 819.16 | 636.59 | 578.05 | 591 | 409.39 | -68.51 |
Other Assets | 152.82 | 127.29 | 751.85 | 114.93 | 112.55 | 110.49 | 231.1 | 469.61 | 427.64 | 1,106.51 |
Total Assets | 11,899.01 | 10,823.02 | 11,301.35 | 9,206.61 | 7,729.13 | 6,118.92 | 5,568.68 | 4,853.23 | 4,048.39 | 4,263.65 |
Contingent Liabilities | 100.88 | 289.52 | 274.92 | 287.75 | 278.73 | 329.43 | 277.3 | 310.82 | 684.87 | 354.94 |
Cash Flow (Figures in Rs. Crores)
Net Profit before Tax and Extr... | 2,023.13 |
Depreciation | 299.3 |
Interest (Net) | -163.36 |
Dividend Received | 0.19 |
P/L on Sales of Assets | 3.18 |
P/L on Sales of Invest | -14.63 |
Prov. and W/O (Net) | 181.44 |
P/L in Forex | 58.89 |
Total Adjustments (PBT and Ext... | 383.57 |
Operating Profit before Workin... | 2,406.7 |
Trade and 0ther Receivables | -221.99 |
Inventories | -73.4 |
Trade Payables | 525.28 |
Loans and Advances | -135.11 |
Total Adjustments (OP before W... | -51.69 |
Cash Generated from/(used in) ... | 2,355.01 |
Direct Taxes Paid | -406.94 |
Total Adjustments(Cash Generat... | -406.94 |
Cash Flow before Extraordinary... | 1,948.07 |
Net Cash from Operating Activi... | 1,948.07 |
Purchased of Fixed Assets | -259.29 |
Sale of Fixed Assets | 72.48 |
Purchase of Investments | -53.37 |
Interest Received | 239.28 |
Net Cash used in Investing Act... | -1,010.55 |
Proceed from 0ther Long Term B... | 40 |
Of the Short Term Borrowings | -520.89 |
Of Financial Liabilities | -32.32 |
Dividend Paid | -540.49 |
Interest Paid | -91.31 |
Net Cash used in Financing Act... | -1,145.01 |
Net Profit before Tax and Extr... | 1,881.03 |
Depreciation | 244.35 |
Interest (Net) | -145.56 |
Dividend Received | 2.61 |
P/L on Sales of Assets | 2.84 |
P/L on Sales of Invest | -13.96 |
Prov. and W/O (Net) | 91.24 |
P/L in Forex | 38.2 |
Total Adjustments (PBT and Ext... | 211.74 |
Operating Profit before Workin... | 2,092.77 |
Trade and 0ther Receivables | -43.75 |
Inventories | -124.91 |
Trade Payables | 355.24 |
Loans and Advances | -69.61 |
Total Adjustments (OP before W... | -53.38 |
Cash Generated from/(used in) ... | 2,039.39 |
Direct Taxes Paid | -352.83 |
Total Adjustments(Cash Generat... | -352.83 |
Cash Flow before Extraordinary... | 1,686.56 |
Net Cash from Operating Activi... | 1,686.56 |
Purchased of Fixed Assets | -106.68 |
Sale of Fixed Assets | 6.24 |
Purchase of Investments | -18.9 |
Interest Received | 190.97 |
Net Cash used in Investing Act... | -865.6 |
Of the Short Term Borrowings | -344.37 |
Of Financial Liabilities | -14.51 |
Dividend Paid | -538.04 |
Interest Paid | -62.12 |
Net Cash used in Financing Act... | -959.04 |
Company Details
Registered Office |
|
Address | Alkem House SenapatiBapat Marg, Lower Parel |
City | Mumbai |
State | Maharashtra |
Pin Code | 400013 |
Tel. No. | 91-22-39829999 |
Fax. No. | 91-22-24952955 |
investors@alkem.com ; contact@alkem.com | |
Internet | http://www.alkemlabs.com |
Registrars |
|
Address | Alkem House SenapatiBapat Marg |
City | Mumbai |
State | Maharashtra |
Pin Code | 400013 |
Tel. No. | 91-22-39829999 |
Fax. No. | 91-22-24952955 |
investors@alkem.com ; contact@alkem.com | |
Internet | http://www.alkemlabs.com |
Management |
|
Name | Designation |
Basudeo N Singh | Executive Chairman |
SANDEEP SINGH | Managing Director |
Mritunjay Kumar Singh | Executive Director |
A K Purwar | Non-Exec. & Independent Dir. |
SANGEETA KAPILJIT SINGH | Non-Exec. & Independent Dir. |
SUDHA RAVI | Non-Exec. & Independent Dir. |
Manish Narang | Company Sec. & Compli. Officer |
Narendra Aneja | Non-Exec. & Independent Dir. |
SARVESH SINGH | Executive Director |
Madhurima Singh | Executive Director |
Sujjain Talwar | Independent Director |
Srinivas Singh | Executive Director |